Exelixis Clinical Site #218

Hangzhou, Zhejiang 310016

0 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma

Studies at this site

• Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy — Running, not enrolling